PDGFRB and invasive breast carcinoma: PDGFRB, detected as being hypermethylated in stage-I BrCa, had been reported to increase proliferation and migration in several cancers [50,51,52], PDGFRB expression was correlated with less favorable clinicopathological parameters and shorter survival in BrCa [22,53].